Zomedica Corp. Depreciation & Amortization 2011-2026 | ZOM

Annual Depreciation & Amortization Zomedica Corp.

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
2.06 M	1.54 M	830 K	426 K	265 K	306 K	277 K	204 K	89.6 K	43.1 K	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
2.06 M	43.1 K	604 K

Quarterly Depreciation & Amortization Zomedica Corp.

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
506 K	509 K	521 K	-	417 K	351 K	334 K	-	198 K	176 K	164 K	-	109 K	161 K	82 K	-	60 K	55 K	59 K	-	78.2 K	77.9 K	76.4 K	-	277 K	277 K	277 K	-	204 K	204 K	204 K	-	89.6 K	89.6 K	89.6 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
521 K	55 K	209 K

Depreciation & Amortization of other stocks in the Drug manufacturers industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
AcelRx Pharmaceuticals ACRX	311 K	-	7.5 %	$ 6.35 M	USA
Adamis Pharmaceuticals Corporation ADMP	1.48 M	-	0.86 %	$ 117 M	USA
Aerie Pharmaceuticals AERI	6.4 M	-	-	$ 754 M	USA
Assertio Holdings ASRT	30 M	$ 19.26	0.26 %	$ 123 M	USA
Agile Therapeutics AGRX	102 K	-	10.11 %	$ 58.2 M	USA
Alimera Sciences ALIM	8.75 M	-	-	$ 142 M	USA
Athenex ATNX	4.47 M	-	-23.39 %	$ 1.76 M	USA
Avadel Pharmaceuticals plc AVDL	2.68 M	-	-	$ 2.06 B	France
Bausch Health Companies BHC	1.26 B	$ 5.41	1.12 %	$ 1.97 B	Canada
Canopy Growth Corporation CGC	21.5 M	$ 1.02	2.0 %	$ 110 M	Canada
Cumberland Pharmaceuticals CPIX	4.9 M	$ 3.1	-2.21 %	$ 43.6 M	USA
Catalent CTLT	489 M	-	-	$ 11.5 B	USA
DURECT Corporation DRRX	31 K	-	-	$ 50.1 M	USA
Eagle Pharmaceuticals EGRX	646 K	-	-39.89 %	$ 27.7 M	USA
Endo International plc ENDP	306 M	-	-	$ 28.9 M	Irlanda
Evolus EOLS	7.51 M	$ 4.16	3.23 %	$ 268 M	USA
Emergent BioSolutions EBS	125 M	$ 8.1	-1.58 %	$ 415 M	USA
Harrow Health HROW	1.32 M	$ 35.13	-0.51 %	$ 1.29 B	USA
Jupiter Wellness JUPW	654 K	-	-	$ 33.6 M	USA
Lannett Company LCI	34.3 M	-	1.15 %	$ 7.11 M	USA
Neoleukin Therapeutics NLTX	3.04 M	-	-	$ 193 M	Canada
OptiNose OPTN	402 K	-	-	$ 1.08 B	USA
Organogenesis Holdings ORGO	13.6 M	$ 2.24	-	$ 295 M	USA
Pacira BioSciences PCRX	78.8 M	$ 22.27	-1.89 %	$ 1.03 B	USA
PetIQ PETQ	44.5 M	-	1.64 %	$ 400 M	USA
PLx Pharma PLXP	116 K	-	-27.8 %	$ 2.56 M	USA
ProPhase Labs PRPH	4.72 M	-	-	$ 5.07 M	USA
Radius Health RDUS	1.16 M	-	-	$ 1.42 B	USA
Recro Pharma REPH	8.22 M	-	-4.76 %	$ 65.3 M	USA
Relmada Therapeutics RLMD	1.26 K	$ 6.9	-1.29 %	$ 272 M	USA
Rockwell Medical RMTI	2.19 M	$ 0.96	0.84 %	$ 34.5 M	USA
SCYNEXIS SCYX	580 K	$ 0.92	3.28 %	$ 45.9 M	USA
Solid Biosciences SLDB	1.64 M	$ 7.74	3.34 %	$ 677 M	USA
Sonoma Pharmaceuticals SNOA	138 K	$ 2.33	-1.9 %	$ 2.89 M	USA
Tilray TLRY	35.7 M	$ 6.66	1.68 %	$ 4.12 B	Canada
Veru VERU	268 K	$ 2.4	4.8 %	$ 324 M	USA
Viatris VTRS	2.74 B	$ 13.41	-0.22 %	$ 16.1 B	USA
cbdMD YCBD	452 K	$ 0.73	-0.4 %	$ 3.15 M	USA
Zynerba Pharmaceuticals ZYNE	219 K	-	-	$ 55.5 M	USA
Tricida TCDA	442 K	-	-	$ 3.25 M	USA
China Pharma Holdings CPHI	1.5 M	$ 0.61	-2.94 %	$ 2.62 M	China
TherapeuticsMD TXMD	384 K	$ 2.2	10.0 %	$ 25.5 M	USA